Nintenib 150 mg Capsule

Introduction of Nintenib 150 mg Capsule

Nintenib 150 mg Capsule belongs to the group of drugs called tyrosine kinase inhibitors and is used to treat idiopathic pulmonary fibrosis. Nintenib Capsule prevents changes in lung tissue and slows the progression of fibrosis in people with chronic interstitial lung disease. Additionally, Nintenib 150 mg is indicated in combination with docetaxel for treating non-small cell lung cancer of adenocarcinoma type in adults who have received first-line chemotherapy.

Nintenib 150 mg may cause common adverse effects like diarrhoea, nausea, stomach pain, vomiting, liver issues, decreased appetite, headache, weight loss, and high blood pressure. If you experience any of these symptoms, it's important to inform your doctor.

Before using Nintenib 150 mg Capsule, inform your doctor of any heart disease, liver problems, history of blood clots or bleeding disorders, and recent abdominal surgery. Also, inform your healthcare provider of all medications you're taking as Nintenib 150 mg Capsule may interact with them.

Nintenib Capsule is not recommended during pregnancy or breastfeeding and both males and females must use effective contraception during treatment to avoid pregnancy as it can cause harm to an unborn baby and lead to birth defects or death.

Nintenib Capsule should be taken orally, ideally with food, and should be swallowed whole with water without being chewed or crushed. If a dose is missed, it should be taken at the next scheduled time and at the recommended dose. Do not take an extra dose if a dose is missed.

Uses of Nintenib 150 mg Capsule

Idiopathic Pulmonary Fibrosis: Nintenib 150 mg Capsule is used to treat Idiopathic Pulmonary Fibrosis (IPF), a chronic lung disease that involves thickening and scarring of lung tissue causing difficulty breathing.

Non-small cell lung cancer: Nintenib 150 Capsule is used in the treatment of Non-small cell lung cancer (NSCLC), which can occur in any part of the lung and can spread to other parts of the body. Symptoms of non-small cell lung cancer include coughing, chest pain, shortness of breath, and weight loss.

Benefits of Nintenib 150 mg Capsule

Nintenib Capsule is a drug used for treating Idiopathic Pulmonary Fibrosis (IPF). Nintenib 150 mg Capsule can slow the progression of IPF and enhance breathing. Additionally, Nintenib is combined with docetaxel for the treatment of Non-small Cell Lung Cancer (NSCLC) to slow down cancer cell growth. Nintenib 150 Capsule may also help to decrease the rate of decline in lung function in patients with systemic sclerosis-associated interstitial lung disease.

Side Effects of Nintenib 150 mg Capsule

​​​​​​Like all medications, Nintenib 150 mg Capsule can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.​

Most Common Side Effects of Nintenib 150 mg Capsule

• Nausea
• Vomiting
• Diarrhoea
• Stomach upset
• ​Loss of appetite
• Weight loss
• Fatigue
• Headache
• Unhealed wound
  

Common Side Effects of Nintenib 150 mg Capsule

• Altered blood pressure
• Liver problems (jaundice)
• Dark brown urine
• Yellowing of the skin
• Lack of energy
• Shortness of breath
• Numbness or weakness
• Difficulty in speech
• Malena ( blood in stool)

How to Use Nintenib 150 mg Capsule?

​Nintenib Capsule should be taken orally, ideally with food, and should be swallowed whole with water without being chewed or crushed. If a dose is missed, it should be taken at the next scheduled time and at the recommended dose. Do not take an extra dose if a dose is missed.​

How Nintenib 150 mg Capsule Works?

Nintenib Capsule is a tyrosine kinase inhibitor drug. Nintenib 150 mg works by blocking certain enzymes in the body called tyrosine kinases that are involved in the growth and spread of certain types of cells, including cancer cells and cells involved in fibrosis. By blocking these enzymes, Nintenib helps to slow the progression of diseases such as idiopathic pulmonary fibrosis and non-small cell lung cancer. Nintenib 150 mg Capsule is usually taken orally and is usually well-tolerated, although some side effects such as diarrhoea, nausea, and stomach pain may occur. It is important to follow your doctor's instructions and report any side effects to your doctor.

Safety Advices Nintenib 150 mg Capsule

Kidney

Use with Caution

Alcohol

Unsafe

Pregnancy

Unsafe

Breastfeeding

Unsafe

Driving

Unsafe

Liver

Use with Caution

References

1. Nintib (nintedanib Capsules 100 Mg,150 Mg) To Treat Idiopathic Pulmonary Fibrosis, In Continuation Of Its Fight Against Rare Lung Diseases, Cipla Ltd. India, Product Leaflet 

2. Nintedanib Soft Gelatin Capsules, Boehringer Ingelheim India Private Limited. India, Product Leaflet 

3. Ofev (nintedanib) Capsules, For Oral Use, Boehringer Ingelheim Pharmaceuticals, Inc. USA, Available Form 

4. Nintedanib 100mg And 150mg Capsules, Ofev, Boehringer Ingelheim, Scottish Medicines Consortium, Product Leaflet 

5. Ofev 150 Mg Soft Capsules, Boehringer Ingelheim Pharma Gmbh & Co. Kg, Available Form 

6. Nintedanib, Drugs.com, Available Form